Los diluyentes de la sangre pertenecen al grupo de medicamentos que se conocen como anticoagulantes. “Anti” significa ‘en contra de’ y “coagulante” es. farmacos coagulantes y anticoagulantes pdf download. Quote. Postby Just» Tue Aug 28, am. Looking for farmacos coagulantes y anticoagulantes. 22 mar. fármacos para esse fim. Dois grupos de anticoagulantes orais, inibidores do fator Xa (rivaroxabana, apixabana e edoxabana) e inibidores.

Author: Nishura Daitaur
Country: Cameroon
Language: English (Spanish)
Genre: Sex
Published (Last): 25 November 2013
Pages: 40
PDF File Size: 10.4 Mb
ePub File Size: 18.62 Mb
ISBN: 250-7-60088-955-7
Downloads: 34209
Price: Free* [*Free Regsitration Required]
Uploader: Nikozragore

Com mais detalhes, em 6. This review focuses on a number of molecules of vegetal origin belonging to different chemical classes, with significant anticoagulant and antiplatelet effects. Dypiridamole preserved cowgulantes and reduced blood loss after cardiopulmonary bypass.

farmacos coagulantes y anticoagulantes pdf download – PDF Files

Impact of clopidogrel in patients farmacoe acute coronary syndromes requiring coronary artery bypass surgery: The Abciximab in Ischemic Stroke Investigators. Internal Medicine14 Combination antithrombotic therapy in unstable rest angina and non-Q-wave infarction in nonprior aspirin users: A randomised, double-blind, non-inferiority trial.

Antithrombotic therapy in atrial fibrillation: Warfarin absorption after massive small bowel resection. Haemostasis82 Perioperative management of antithrombotic therapy: The Euro Heart Survey. Effects of pretreatment with clopidogrel and aspirin followed by long term therapy in patients undergoing percutaneous coronary intervention: Spontaneous calcific embolization associated with calcific aortic stenosis.


Apixaban, an oral, direct, selective factor Xa inhibitor, in combination with antiplatelet therapy after acute coronary syndrome: Hamm CW, Braunwald E.

farmacos coagulantes y anticoagulantes pdf download

Tissue plasminogen activator for acute ischemic stroke. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease. Mais recentemente, foi introduzido o prasugrel. Br J Clin Pharmacol. Tirofiban as adjunctive therapy for acute coronary syndromes and percutaneous coronary intervention: Population trends in the incidence and outcomes of acute myocardial infarction.

Recombinant factor VIIa reverses the anticoagulant effect of the long-acting pentasaccharide idraparinux in healthy volunteers.

Randomised comparison of two intensities of oral anticoagulant therapy after tissue heart valve replacement. Subcutaneous adjusted-dose unfractionated heparin versus fixed-dose low-molecular-weight heparin in the initial treatment of venous thromboembolism. Aspirin for preventing the recurrence of venous thromboembolism.

The effect of dipyridamole on the thrombocyte count and bleeding tendency in open-heart surgery.

Role of intracelular signaling events in ADP induced platelet aggregation. Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: Coagukantes of nonrheumatic atrial fibrillation: J Intern Med ; 5: Catastrophic outcomes of noncardiac surgery soon after coronary stenting.


Secondary metabolites from vegetal origin: a potential source of antithrombotic drugs

Residual vein thrombosis to establish duration of anticoagulation after a first episode of deep vein thrombosis: Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation. A risk assessment model for the identification of hospitalized medical patients at risk for venous antickagulantes Terapia anticoagulante no TEV.

Apixaban versus enoxaparin for thromboprophylaxis after hip replacement. Bivalirudin for patients with acute coronary syndromes.

Heparin for the prevention of venous thromboembolism in general medical patients excluding stroke and myocardial infarction. Br J Anaesth ; 3: Recovery of platelet function after discontinuation of clopidogrel treatment in healthy volunteers. Prevention of venous thrombosis in patients with acute intracerebral hemorrhage.

Factors at admission associated with bleeding risk in medical patients: